123 related articles for article (PubMed ID: 3140587)
1. Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
Glazener CM; Kelly NJ; Hull MG
Gynecol Endocrinol; 1987 Dec; 1(4):373-8. PubMed ID: 3140587
[TBL] [Abstract][Full Text] [Related]
2. Occult hyperprolactinemia in infertile women.
Asukai K; Uemura T; Minaguchi H
Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
[TBL] [Abstract][Full Text] [Related]
3. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia in cases of infertility and amenorrhea.
Furuhjelm M; Rydner T; Carlström K
Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
[TBL] [Abstract][Full Text] [Related]
5. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
Aisaka K; Yoshida K; Mori H
Horm Res; 1992; 37 Suppl 1():41-7. PubMed ID: 1427628
[TBL] [Abstract][Full Text] [Related]
8. Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial.
Wright CS; Steele SJ; Jacobs HS
Br Med J; 1979 Apr; 1(6170):1037-9. PubMed ID: 376036
[TBL] [Abstract][Full Text] [Related]
9. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
Prathibha D; Govardhani M; Krishna PT
J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
[TBL] [Abstract][Full Text] [Related]
10. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
11. Luteal phase hyperprolactinemia.
Falk RJ; Anderson L
Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effects.
Nishimura K; Matsumiya K; Tsuboniwa N; Yamanaka M; Koga M; Miura H; Tsujimura A; Uchida K; Kondoh N; Kitamura M; Okuyama A
Arch Androl; 1999; 43(3):207-13. PubMed ID: 10624504
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin-releasing hormone and gonadotropin-releasing hormone test to predict effectiveness of bromocriptine therapy in infertile women.
Lin KC; Okamura H; Koshida M; Mori T
Fertil Steril; 1986 Nov; 46(5):846-51. PubMed ID: 3096783
[TBL] [Abstract][Full Text] [Related]
14. Exaggerated prolactin response of thyrotropin-releasing hormone in women with anovulatory cycles: possible role of endogenous estrogens and effect of bromocriptine.
Peillon F; Vincens M; Cesselin F; Doumith R; Mowszowicz I
Fertil Steril; 1982 Apr; 37(4):530-5. PubMed ID: 6802681
[TBL] [Abstract][Full Text] [Related]
15. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
Rea N; Bove F; Gentile A; Parmeggiani U
Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
[TBL] [Abstract][Full Text] [Related]
16. [Studies on prolactin secreting capacity in the ovulatory infertile patients with transient hyperprolactinemia].
Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):662-71. PubMed ID: 3089848
[TBL] [Abstract][Full Text] [Related]
17. Prolactin levels and bromocriptine treatment of short luteal phase.
Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between luteal function and prolactin in infertile women with endometriosis].
Hayashi N; Taketani Y; Mizuno M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1720-4. PubMed ID: 2512358
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
20. Effects of prolactin and bromocriptine on the luteal phase in infertile women.
Fredricsson B; Carlström K; Björk G; Messinis I
Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):319-33. PubMed ID: 6785120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
